ZAMBON, ALBERTO ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 45
EU - Europa 43
AS - Asia 35
Totale 123
Nazione #
US - Stati Uniti d'America 45
CN - Cina 20
SG - Singapore 15
IT - Italia 13
SE - Svezia 9
RU - Federazione Russa 5
DE - Germania 4
FI - Finlandia 4
NL - Olanda 3
FR - Francia 2
GR - Grecia 2
MK - Macedonia 1
Totale 123
Città #
Milan 10
New York 10
Shanghai 10
Ashburn 7
Singapore 7
Boardman 4
Athens 2
Dallas 2
Helsinki 2
Lappeenranta 2
Lawrence 2
Moscow 2
Princeton 2
Shenzhen 2
Amsterdam 1
Beijing 1
Bitola 1
Bordeaux 1
Dalian 1
Essen 1
Fontainebleau 1
Hangzhou 1
Los Angeles 1
Monza 1
Naaldwijk 1
Philadelphia 1
Rome 1
Zola Predosa 1
Totale 78
Nome #
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 29
Metachromatic leukodystrophy: A single-center longitudinal study of 45 patients 24
A multicenter retrospective study of charcot-marie-tooth disease type 4B (CMT4B) associated with mutations in myotubularin-related proteins (MTMRs) 20
Expanding the spectrum of neonatal-onset AIFM1-associated disorders 18
Interstitial 6q deletion in a patient presenting with drug-resistant epilepsy and Prader-Willi like phenotype: An electroclinical description with literature review 18
UNRAVELLING THE PHENOTYPIC SPECTRUM OF INDIVIDUALS WITH DUCHENNE MUSCULAR DYSTROPHY 17
Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation 9
Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy 6
Totale 141
Categoria #
all - tutte 1.312
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.312


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225 1 0 1 1 0 0 1 0 0 0 1 0
2022/202323 5 4 2 1 1 1 0 2 0 3 1 3
2023/202463 0 4 8 6 6 11 0 6 1 1 11 9
2024/202550 14 4 7 11 14 0 0 0 0 0 0 0
Totale 141